NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

A U.S. Centers for Disease Control and Prevention (CDC) advisory committee on Thursday recommended meningitis B vaccines for people at high risk aged 10 to 25, a population that Pfizer Inc and Novartis criticized as too narrow. Pfizer's Trumenba, like Novartis' new vaccine Bexsero, recently won U.S. marketing approval to…

news

Glenmark Pharmaceuticals announced receipt of approval from the US health regulator to sell its generic version of AbbVie Inc's blood pressure drug Tarka in the American market. The approval for trandolapril and verapamil hydrochloride extended release tablets has been granted to Glenmark Generics Inc, a subsidiary of Glenmark Generics Ltd.…

news

Belgian pharmaceutical company UCB forecast improved income in 2015 on Friday based on continued growth of its three newer drugs, although its profit outlook is not as bullish as that of the market. UCB forecast revenue this year of 3.55-3.65 billion euros ($3.98-$4.09 billion), recurring core profit (REBITDA) of 710-740…

news

Lantern Pharma Inc. has landed a nearly $1 million investment from Dallas-based Green Park & Golf Ventures and other investors. The Dallas startup, which focuses on novel cancer treatments, is a graduate of the 2014 Health Wildcatters class. "The investment from GPG helps us bring the next generation of cancer…

news

Hetero Healthcare Limited, the first pharma company in India to launch anti-H1N1 drug Oseltamivir in retail market, today said it has increased its Fluvir production by 400 per cent to address the present swine flu outbreak across the country. Considering the gravity of the present swine flu situation where more…

news

Smooth Drug Development  announced gaining the internationally renowned  ISO 9001:2008 certification. This important acknowledgment further strengthens the company's position within Russian, Eastern European, and international markets. Dmitry Morozovsky, MD, EMBA, CEO of Smooth Drug Development, says: "For Smooth Drug Development's team, the fact that the Company has been awarded ISO…

news

Sanofi announced that the U.S. Food and Drug Administration or (FDA)approved Toujeo (insulin glargine [rDNA origin] injection, 300 U/mL), a once-daily long-acting basal insulin, to improve glycemic control in adults living with type 1 and type 2 diabetes. Toujeo is expected to be available in the U.S. at the beginning…

news

A late-phase clinical study of Amgen Inc.’s experimental treatment for secondary hyperparathyroidism in patients with chronic kidney disease showed a higher percentage of patients responded to its treatment. The 683-patient study compared results of patients who received Amgen’s AMG 416 against those treated with calcium-lowering cinacalcet, which is marketed in…

news

Porton Fine Chemicals Ltd Says plans to acquire Jiangxi Dongbang Pharmaceutical Co Ltd for 260 million yuan ($41.57 million) via cash and share issue Says plans to raise up to 65 million yuan in private placement of shares to fund acquisition Says shares to resume trading on Feb. 25  …

news

Dublin-based drugmaker Shire said on Tuesday it had bought U.S. firm Meritage Pharma for at least $70 million, boosting its gastrointestinal drugs business. Shire said it had obtained rights to buy privately-held Meritage in connection with its $4.2 billion acquisition of rare disease specialist Viropharma in 2014. The fee could…